Autophagy, a cellular process for organelle and protein turnover, regulates innate immune responses. Here we demonstrate that depletion of the autophagic proteins LC3B and beclin 1 enhanced the activation of caspase-1 and secretion of interleukin 1β (IL-1β) and IL-18. Depletion of autophagic proteins promoted the accumulation of dysfunctional mitochondria and cytosolic translocation of mitochondrial DNA (mtDNA) in response to lipopolysaccharide (LPS) and ATP in macrophages. Release of mtDNA into the cytosol depended on the NALP3 inflammasome and mitochondrial reactive oxygen species (ROS). Cytosolic mtDNA contributed to the secretion of IL-1β and IL-18 in response to LPS and ATP. LC3B-deficient mice produced more caspase-1-dependent cytokines in two sepsis models and were susceptible to LPS-induced mortality. Our study suggests that autophagic proteins regulate NALP3-dependent inflammation by preserving mitochondrial integrity.
Autophagy, an evolutionarily conserved cellular process, facilitates the turnover of damaged proteins and organelles such as mitochondria 1 . During autophagy, cytosolic constituents are engulfed into doublemembrane-bound vesicles called 'autophagosomes' , which are subsequently delivered to the lysosomes for degradation 1 . Accumulating evidence suggests that autophagic dysfunction is associated with aging and human diseases, including cancer, and neurodegenerative disorders 2 . Autophagy also participates in the clearance of intracellular bacteria, viruses and protozoa from host cells 2, 3 . In addition, autophagy affects diverse immune system functions such as antigen presentation, lymphocyte development and cytokine secretion by cells of the immune response 3 . The involvement of autophagy in the secretion of proinflammatory cytokines has been demonstrated in mice with deletion of the gene encoding the autophagy protein ATG16L1, which produce excessive amounts of interleukin 1β (IL-1β) and IL-18 in response to lipopolysaccharide (LPS) and other pathogen-associated molecular patterns 4 . That observation suggested that mutations in genes encoding autophagy proteins may directly or indirectly deregulate the secretion of IL-1β and IL-18. However, the mechanism by which autophagy regulates cytokine secretion is poorly understood.
In macrophages, the secretion of IL-1β and IL-18 is controlled by the inflammatory signaling platform called the 'inflammasome' [5] [6] [7] . This is a multiprotein complex that mediates the cleavage and activation of caspase-1, leading to the maturation and secretion of IL-1β and IL-18. Cytoplasmic receptors of the NALP (also called NLR) family are critical components of the inflammasome and interact with apoptosis-associated adaptor protein ASC, which recruits the precursor form of caspase-1. Mice lacking NALP3, ASC or caspase-1 show a considerable defect in the production of mature IL-1β and IL-18 after challenge with LPS and ATP and are resistant to LPS-induced lethality 8, 9 . Given the pivotal role of caspase-1 activation in the secretion of IL-1β and IL-18 and in LPS-induced inflammation in vivo, we hypo thesized that autophagy-related proteins might regulate the secretion of proinflammatory cytokines via modulation of caspase-1 activation. In this study, we describe a pathway by which autophagic proteins regulate caspase-1-mediated innate immune responses through their role in preserving mitochondrial homeostasis.
RESULTS

Deficiency in autophagic proteins activates caspase-1
To examine the role of autophagic proteins during inflammasome activation, we isolated macrophages from mice with deletion of autophagy genes, pretreated the cells with LPS and then stimulated them with ATP. ATP-driven activation of caspase-1 in LPS-primed macrophages is an established model for NALP3 inflammsome-mediated activation of caspase-1 in vitro, which acts through the signaling pathways mediated by the purinergic receptor P2X7 (P2X7 receptor) and Toll-by Map1lc3b -/and Becn1 +/macrophages than by the corresponding wild-type macrophages (Fig. 1b) . We observed that unlike IL-1β secretion, secretion of cathepsin B, which is dependent on the extracellular calcium concentration 12 , was not greater in either Map1lc3b -/or Becn1 +/cells (Fig. 1a) . In addition, secretion of tumor necrosis factor (TNF) in response to LPS was similar among the genotypes (Fig. 1b) . Consistent with that observation, we found that activation of the transcription factor NF-κB by LPS was not different in Map1lc3b -/macrophages relative to its activation in wild-type cells (Supplementary Fig. 2) . We similarly observed more caspase-1 activation, IL-1β cleavage and secretion of IL-1β and IL-18 in autophagy protein-deficient bone marrow-derived macrophages (BMDMs) in response to stimulation with LPS and ATP ( Fig. 1c) . Treatment of macrophages with z-YVAD-fmk, a caspase-1 inhibitor, suppressed the enhanced IL-1β secretion in Map1lc3b -/and Becn1 +/macrophages ( Fig. 1d) , which confirmed that the greater abundance of IL-1β was the consequence of more caspase-1 activity. Collectively these results demonstrate that depletion of autophagy proteins enhances caspase-1 activation and the secretion of IL-1β and IL-18 in macrophages in response to LPS and ATP.
Depletion of autophagic proteins impairs mitochondrial homeostasis
As autophagy is critical for the removal of old or damaged organelles, we investigated the ultrastructural phenotypes of autophagy protein-deficient (Map1lc3b -/or Becn1 +/-) macrophages during treatment with LPS and ATP. Under basal conditions, we did not observe morphological differences between Map1lc3b +/+ and Map1lc3b -/macrophages by transmission electron microscopy ( Fig. 2a) . However, treatment with LPS and ATP produced a greater abundance of swollen mitochondria with severely disrupted cristae in Map1lc3b -/cells than in Map1lc3b +/+ macrophages ( Fig. 2a) . Becn1 +/cells also showed evidence of swollen or injured mitochondria in response to treatment with LPS and ATP ( Fig. 2b) . Furthermore, we also observed that macrophages from Map1lc3b -/and Becn1 +/mice generated more mitochondrial superoxide anion radical (O 2 -) at baseline, as detected by the fluorescence of MitoSOX (a mitochondrial superoxide indicator; Fig. 2c ), indicative of more mitochondrial production of reactive oxygen species (ROS) and mitochondrial dysfunction 13, 14 . We further assessed the functional mitochondrial pool in wild-type cells and cells with deletion of autophagic proteins through the use of MitoTracker Deep Red, a fluorescent probe sensitive to the mitochondrial inner transmembrane potential. To measure the total mitochondrial pool, we counterstained cells with MitoTracker Green, a probe that stains mitochondrial membrane lipids independently of membrane potential 13 . Treatment with LPS and ATP resulted in a decrease in the percentage of intact mitochondria (positive for MitoTracker Deep like receptor 4 (refs. 8,9) . First, we examined the effect of deficiency of the autophagic protein LC3B (microtubule-associated protein 1 light chain 3B) on the activation of caspase-1 in thioglycollate-elicited peritoneal macrophages. LC3B is a downstream constituent of the autophagic pathway and participates in autophagosome formation and maturation 1, 10 . LC3B-deficient (Map1lc3b -/-) macrophages had more of the active, cleaved (10-kilodalton) form of caspase-1 in response to treatment with LPS and ATP than did wild-type (Map1lc3b +/+ ) macrophages ( Fig. 1a) . Additionally, the cleaved form of IL-1β, produced from the precursor pro-IL-1β through the action of activated caspase-1, was greater in abundance in the lysates and culture medium of Map1lc3b -/macrophages ( Fig. 1a) . Similarly, acute knockdown of LC3B mediated by small interfering RNA also enhanced IL-1β secretion in peritoneal macrophages ( Supplementary Fig. 1 ). We next sought to determine whether beclin 1, a critical upstream regulator of autophagy, affects caspase-1 activation. Beclin 1 associates with the complex of hVPS34 and class III phosphatidylinositol-3-OH kinase, which is responsible for the initiation of autophagosome formation 1,2 . As homozygous deletion of beclin 1 (Becn1 -/-) is lethal to mice, we used peritoneal macrophages from Becn1 +/mice 11 . Similar to LC3Bdeficient cells, Becn1 +/macrophages had more caspase-1 activation and cleaved IL-1β after treatment with LPS and ATP than did wildtype (Becn1 +/+ ) cells treated with LPS and ATP ( Fig. 1a) . Moreover, there was also more secretion of IL-1β and IL-18 into the medium A r T I C l e S mitochondrial genome ( Supplementary Fig. 3 ). The expression of cytochrome c, a mitochondriarelated protein encoded by nuclear DNA, was not affected by EtBr treatment ( Supplementary  Fig. 3 ). J774A.1 macrophages conditioned with EtBr at a concentration of 100 ng/ml, which we called 'ρ 0 J774A.1 cells' , had lower mitochondrial production of ROS, both basal and inducible by rotenone (a potent mitochondrial ROS generator), as measured by MitoSOX fluorescence (Supplementary Fig. 4 ). EtBr treatment inhibited caspase-1 activation of IL-1β cleavage and the secretion of IL-1β and IL-18 in response to treatment with LPS and ATP in a dose-dependent way but did not decrease the amount of pro-IL-1β ( Fig. 3a) . We also observed that EtBr treatment did not alter the amount of IL-1β mRNA either under basal conditions or after LPS stimulation (data not shown). At the time of maximum ATPdependent activation of caspase-1 in LPS-primed macrophages, the ρ 0 J774A.1 macrophages in contrast had nearly complete attenuation of the response (Fig. 3b) . In contrast to the inhibition of IL-1β secretion, the ρ 0 phenotype did not result in less secretion of TNF in response to LPS and ATP ( Fig. 3c ). In addition, neither secretion of cathepsin B (Fig. 3a) nor expression of ASC protein ( Fig. 3b ) was affected by EtBr treatment.
These data indicate that respiring mitochondria are specifically required for caspase-1 activation in response to treatment with LPS and ATP in macrophages.
Mitochondrial ROS are required for caspase-1 activation
Published studies of mice with deletion of the gene encoding ATG5 have suggested a relationship between autophagic proteins and signaling through mitochondrial generation of ROS in the context of viral infection 13 . We therefore examined the relationship between mitochondrial ROS and caspase-1 activity in macrophages stimulated with LPS and ATP. We observed that treatment with the mitochondrial complex I inhibitor rotenone enhanced caspase-1 activation and IL-1β secretion in macrophages stimulated with LPS and ATP ( Fig. 3d) , whereas this compound did not affect TNF secretion. The potent enhancement of LPS-and ATP-induced IL-1β secretion by rotenone was abolished in ρ 0 J774A.1 macrophages ( Fig. 3e) . We next examined whether mitochondria-specific generation of ROS contributed to the activation of caspase-1 by LPS and ATP. Treatment of macrophages with the mitochondria-targeted antioxidant Mito-TEMPO, a scavenger specific for mitochondrial ROS 21, 22 , inhibited the secretion of IL-1β and IL-18 in a dose-dependent manner in BMDMs but did not affect TNF secretion in response to LPS and ATP ( Fig. 3f) . We also found that Mito-TEMPO did not inhibit IL-1β secretion induced by LPS and monosodium urate, which stimulates a pathway alternative to activation of the NALP3 inflammasome ( Supplementary Fig. 5 ).
Furthermore, the effect of Mito-TEMPO on IL-1β secretion by LPS and the synthetic B-form double-stranded DNA poly(dA:dT), representative of the AIM2 inflammasome pathway [23] [24] [25] , was negligible compared with its effect in the LPS and ATP model ( Supplementary  Fig. 5 ). Given the importance of mitochondrial ROS in caspase-1 activation induced by LPS and ATP in wild-type cells, we next examined the effect of mitochondrial ROS on caspase-1 activation
Red and MitoTracker Green) in Map1lc3b +/+ macrophages, from 76.9% to 66.2% of the total population ( Fig. 2d) . In contrast, treatment with LPS and ATP decreased the functional mitochondrial pool in Map1lc3b -/macrophages from 77.7% to 43.2% of the total mitochondria. These results reflected a ~1.6-fold greater mitochondrial injury index in Map1lc3b -/macrophages than in wild-type cells (Fig. 2d) . These data suggest that disruption of the autophagic protein LC3B generates a defect in mitochondrial homeostasis, which results in a greater basal amount of mitochondrial ROS production and renders mitochondria more susceptible to damage by treatment with LPS and ATP.
Impaired caspase-1 activation in ρ 0 macrophages Mitochondrial abnormalities have been linked to the pathogenesis of human diseases, such as type II diabetes, Parkinson's disease and Alzheimer's disease [15] [16] [17] . To assess the importance of mitochondria in caspase-1 activation, we cultured J774A.1 mouse macrophages with ethidium bromide (EtBr) to generate macrophages with the mitochondrial DNA (mtDNA)-deficient ρ 0 phenotype 18 . In animal or human cells, chronic treatment with EtBr inhibits the replication of mtDNA, which results in the depletion of critical mitochondrial proteins encoded by the mitochondrial genome, leading to deficiency in oxidative phosphorylation as well as auxotrophy for uridine and pyruvate 19, 20 . The ρ 0 cells are widely used to investigate relationships among mtDNA, mitochondrial dysfunction and a variety of cellular processes 20 . We confirmed that EtBr treatment diminished the mtDNA copy number in J774A.1 macrophages in a dose-dependent way and depleted the cells of cytochrome c oxidase 1, which is encoded by the A r T I C l e S only by attenuation of respiratory chain activity and ROS production but also by diminished mtDNA content, we examined the potential role of mtDNA in caspase-1-dependent responses. LPS and ATP induced the cytosolic accumulation of mtDNA in wild-type macrophages (Fig. 4c) . The copy number of nuclear DNA (encoding 18S ribosomal RNA) in cytosol was not increased by stimulation with LPS and ATP (data not shown). Rotenone treatment greatly augmented the copy number of cytosolic mtDNA in cells treated with LPS and ATP ( Fig. 4c) . Furthermore, the mitochondria-targeted antioxidant Mito-TEMPO suppressed the release of mtDNA into the cytosol triggered by treatment with LPS and ATP ( Fig. 4d) . Inhibition of MPT by treatment with cyclosporine A also resulted in a lower cytosolic mtDNA copy number during treatment with LPS and ATP, to an amount equivalent to control values ( Fig. 4e) . Treatment with LPS and ATP produced approximately twofold more mtDNA translocation in Map1lc3b -/and Becn1 +/macrophages than in wild-type cells (Fig. 4f) . These data indicate that more activation of caspase-1 in autophagic protein-deficient cells is accompanied by greater release of mtDNA into the cytosol through more mitochondrial membrane in macrophages depleted of autophagic proteins. We observed that Mito-TEMPO abrogated the apparent increase in IL-1β secretion and caspase-1 activation in Map1lc3b -/and Becn1 +/macrophages in response to LPS and ATP ( Fig. 3g,h) . Mitochondrial ROS production is a prerequisite for mitochondrial membrane permeability transition (MPT) in several models 26 . Next we examined whether MPT is necessary for caspase-1 activation caused by LPS and ATP. Cotreatment with LPS and cyclosporine A, a potent inhibitor of MPT, inhibited the secretion of IL-1β but not of TNF in response to LPS and ATP in both wild-type macrophages and macrophages in which autophagy proteins were depleted ( Fig. 4a,b ). Collectively these data suggest that the stimulation of caspase-1 activation by LPS and ATP is dependent on mitochondrial generation of ROS and MPT.
Translocation of mtDNA to the cytosol It has been shown that mtDNA is a damage-associated molecular pattern when liberated into the extracellular space 27 . As ρ 0 macrophages, which have compromised caspase-1 activation, are characterized not 
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Caspase-1 p10 A r T I C l e S given in addition to LPS and ATP (Fig. 5c) . Approximately 50% of the enhancement of IL-1β secretion noted in wild-type macrophages after treatment with LPS, ATP and mtDNA was preserved in Aim2 -/cells (Fig. 5c) .
In the absence of ATP, as expected, the IL-1β secretion induced by mtDNA transfection observed in Aim2 +/+ macrophages was impaired in Aim2 -/cells (Fig. 5c) , which suggested that transfection of mtDNA activated mainly the AIM2 inflammasome in macrophages stimulated with LPS alone. Transfection of mtDNA also produced dosedependent enhancement of IL-18 secretion in Aim2 -/cells stimulated with LPS and ATP but did not affect TNF production (Fig. 5d) .
Notably, pretreatment with DNase I abolished the stimulatory effects of our mtDNA preparation ( Fig. 5d ). Together these data indicate that mtDNA served as an AIM2-independent coactivator of caspase-1 in conjunction with LPS and ATP. Furthermore, we found that the decrease in cytosolic mtDNA produced by transfection of DNase I coincided with inhibition of caspase-1 activation by treatment with LPS and ATP.
NALP3 mediates release of mtDNA ROS generation activates the NALP3 inflammasome, a complex critical for the activation of caspase-1 by LPS and ATP 28 . Therefore, we examined the contribution of NALP3 to the caspase-1 phenotype we observed in autophagic protein-deficient macrophages. Glybenclamide and Bay 11-7082, inhibitors of activation of the NALP3 inflammasome 29, 30 , suppressed the increased secretion of IL-1β and IL-18 in Map1lc3b -/and Becn1 +/macrophages in response to LPS and ATP (Fig. 6a,b) as well as in rotenone-treated cells (Supplementary Fig. 6) . Similarly, genetic deficiency in NALP3 abolished the effect of rotenone on the secretion of IL-1β and IL-18 ( Fig. 6c) , which again suggested that NALP3 is critically involved in mitochondrial ROS-mediated activation of caspase-1 in macrophages. As mitochondrial ROS also promote the release of mtDNA, we tested whether NALP3 is involved in this release. We observed that NALP3 deficiency suppressed the release of mtDNA into the cytosol in response to treatment with LPS and ATP (Fig.  6d) . We obtained similar results with ASC-deficient macrophages (Fig. 6e) . We also observed that release of cytochrome c was slightly lower in NALP3-deficient cells after stimulation (Fig. 6d) . Notably, the generation of mitochondrial ROS induced by LPS and ATP was not affected by deficiency in NALP3 (Fig. 6f) , which suggested that NALP3 is not required for the generation of mitochondrial ROS by treatment with LPS and ATP. However, deletion of the gene encoding NALP3 inhibited the loss of mitochondrial membrane potential in response to treatment with LPS and ATP (Fig. 6g) . These results could not be explained by a lower rate of apoptosis of NALP3-deficient macrophages than of wild-type cells, as there was no difference between NALP3-deficient and ASC-deficient macrophages in their overall apoptotic response to stimulation with LPS and ATP, as determined by annexin V staining (Fig. 6h) . Collectively our data demonstrated that the enhanced caspase-1 activation in permeability. Furthermore, both caspase-1 activation and mtDNA release were dependent on the generation of mitochondrial ROS in our system.
Cytosolic mtDNA is a coactivator of caspase-1
To examine the role of endogenous cytosolic mtDNA in caspase-1 activation during stimulation with LPS and ATP, we delivered DNase I into wild-type macrophages and then stimulated them with LPS and ATP. We observed that secretion of IL-1β was lower in the cells given DNase I than in cells given the control protein lactate dehydrogenase or heat-inactivated DNase I preparations (Fig. 5a) . In contrast, LPSand ATP-inducible secretion of TNF was not sensitive to transfer of either DNase I or control protein (Fig. 5a) . Under these conditions, transfer of DNase I effectively reversed the cytosolic accumulation of mtDNA induced by LPS and ATP, as confirmed by RT-PCR (Fig. 5b) . Transfer of control protein or heat-inactivated DNase I did not affect cytosolic mtDNA copy number during stimulation with LPS and ATP (Fig. 5b) .
To directly assess the bioactivity of mtDNA in isolation from other mitochondrial components, we next transfected macrophages with mtDNA in conjunction with treatment with LPS and ATP. However, we recognized that transfection of exogenous DNA into macrophages has been shown to activate the AIM2 inflammasome, a complex that is dispensable for the effects of LPS and ATP on caspase-1 activation [23] [24] [25] (Fig. 5c) . Therefore, we used AIM2-deficient (Aim2 -/-) macrophages to model the effects of mtDNA on caspase-1 activation without the effects of AIM2. In Aim2 +/+ macrophages, transfection of mtDNA produced enhancement of IL-1β secretion when mtDNA was Consistent with the results we obtained with macrophages, serum concentrations of IL-1β and IL-18 were significantly higher in endotoxemic Map1lc3b -/mice than in their wild-type littermates (Fig. 7a) , whereas TNF production was similar (Supplementary Fig. 7) .
Notably, Map1lc3b -/mice were more susceptible to LPS-induced lethality than were Map1lc3b +/+ mice. At 6 d after LPS injection, 90% of Map1lc3b -/mice had died, whereas 50% of Map1lc3b +/+ mice cells depleted of autophagic proteins required activation of the NALP3 inflammasome. Moreover, the NALP3 inflammsome was required for MPT and subsequent translocation of mtDNA to the cytosol in response to LPS and ATP.
Greater susceptibility to LPS with LC3B deficiency Finally, we tested the in vivo relevance of autophagic regulation of caspase-1 activity in two different animal models of sepsis. We used endotoxemic mice, which are commonly used as a model of septic shock. We also examined the effect of autophagic proteins on cas- A r T I C l e S and dysfunction after treatment with LPS and ATP. The changes to mitochondria after treatment with LPS and ATP are important because we observed that the loss of mitochondrial integrity was critical for the enhanced activation of caspase-1 both in wild-type macrophages and in macrophages depleted of autophagic proteins (Map1lc3b -/and Becn1 +/-). The enhanced generation of mitochondrial ROS by Map1lc3b -/and Becn1 +/macrophages was sufficient to explain their greater efficiency of caspase-1 activation in our model. As a consequence of mitochondrial ROS and subsequent MPT, we found that treatment with LPS and ATP released mtDNA into the cytosolic compartment. Translocation of mtDNA into the cytosol required activation of the NALP3 inflammasome and directly contributed to downstream activation of caspase-1 in response to treatment with LPS and ATP. Notably, we found that Map1lc3b -/and Becn1 +/macrophages released mtDNA in excess quantities into the cytosol in response to treatment with LPS and ATP, which further explained the greater caspase-1 activation and secretion of IL-1β and IL-18 by these cells. Although published reports have described an important role for autophagy in mitochondrial homeostasis 13, 32 , our results have clarified the molecular link between mitochondrial quality control, as regulated by autophagy, and NALP3-dependent activation of caspase-1. We have also identified endogenous cytosolic mtDNA as an additional intracellular second-messenger molecule that connects mitochondrial dysfunction to caspase-1 activation.
Mitochondrial ROS generation was a relatively upstream mechanistic step in our system, as treatment with Mito-TEMPO abolished subsequent caspase-1 activation and mtDNA translocation in response to LPS and ATP. The production of mitochondrial ROS was probably a consequence of ATP-driven activation of the P2X7 receptor 33 , as this has been shown to induce mitochondrial damage 34, 35 and also to contribute to assembly of the NALP3 inflammasome 9 . Notably, we found that Mito-TEMPO did not inhibit IL-1β secretion induced by LPS and monosodium urate. Crystalline particles such as asbestos, silica and monosodium urate have been shown to activate the NALP3 inflammasome through ROS generation induced by phagocytic NADPH oxidase 28, 36 . Thus, although there seems to be a general requirement for ROS in NALP3 inflammasome activation, stimuli may differ in their subcellular source of ROS.
On the basis of published studies 6, 9 , we expected that NALP3 would be situated downstream of both mitochondrial ROS and the release of mtDNA into the cytosol in the caspase-1-activation pathway. However, our results indicated that NALP3 was required at a step upstream of MPT and the release of mtDNA but downstream of mitochondrial production of ROS in response to treatment with LPS and ATP. As deletion of the NALP3-binding partner ASC produced a similar attenuation of the response, it is likely that the NALP3 inflammasome complex is responsible for mediating MPT in our model. At present, it is unclear whether the NALP3 inflammasome is additionally responsible for more distal steps in the caspase-1-activation pathway after treatment with LPS and ATP. Further research will be needed to clarify this point. survived beyond 10 d (Fig. 7b) . Similar to the results obtained with the septic shock model, Map1lc3b -/mice produced significantly higher serum concentrations of not only IL-1β but also IL-18 in response to CLP-induced sepsis (Fig. 7c) . Moreover, serum concentrations of IL-1β and IL-18 were higher in Becn1 +/mice than in wild-type mice after CLP (Fig. 7d) . To correlate our findings obtained with mice to patients with sepsis, we analyzed cytokine secretion in patients admitted to the medical intensive care unit. As the role of IL-1β in human sepsis has been investigated before, we focused on IL-18, whose role in sepsis is not fully characterized 31 . We observed significantly more IL-18 in septic patients in the medical intensive care unit than in control patients admitted to the medical intensive care unit for reasons unrelated to acute infection or inflammation (P = 0.038; Supplementary Fig. 8 and Supplementary Table 1 ). IL-18 was not significantly more abundant in patients with systemic inflammatory response syndrome in the absence of sepsis than in control patients in the intensive care unit (P = 0.67). Together our data demonstrate that autophagic regulation of cytokine production can occur in vivo, leading to regulation of the amount of circulating IL-1β and IL-18. Moreover, more IL-18, one of the products of caspase-1 activity, is specifically associated with severe sepsis in humans.
DISCUSSION
In this study we found that beclin 1 and LC3B, autophagic proteins required for the initial and late phases of autophagosome formation, acted as critical regulators of caspase-1-mediated immune responses in vitro and in vivo. The mechanism by which these autophagic proteins regulated caspase-1 activation was related to their positive contributions to mitochondrial quality control. We observed that macrophages depleted of autophagic proteins accumulated physiologically abnormal mitochondria that produced more ROS at baseline. These abnormal mitochondria were prone to undergo more severe structural derangement 228 volume 8 number 3 march 2011 nature immunology of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
It has been shown that mtDNA stimulates inflammatory responses through Toll-like receptor 9 when released into plasma in humans as a consequence of mechanical trauma 27 . We have shown here that mtDNA also mediated inflammatory responses in the intracellular space through the activation of caspase-1 in response to LPS and ATP, an NALP3 inflammsome model. Many groups have shown that the introduction of exogenous or foreign DNA into the cytosol activates caspase-1 via the AIM2 inflammsome 23, 24 . However, the contribution of endogenous mtDNA to caspase-1 regulation has not been described before, to our knowledge. Our conclusion that mtDNA is important for caspase-1 activation, in response to LPS and ATP, is based on several results. First, respiration-deficient ρ 0 cells, which are also depleted of mtDNA, secreted much less IL-1β and IL-18 when challenged with LPS and ATP. Second, transfection of DNase I into the cytoplasm, which resulted in a lower mtDNA copy number in the cytosol, attenuated IL-1β secretion after treatment with LPS and ATP in macrophages. As nuclear DNA does not translocate to the cytoplasm after treatment with LPS and ATP, the inhibitory effect of DNase I on caspase-1-dependent cytokine secretion correlates with its ability to degrade mtDNA in the cytosol. Third, direct transfection of mtDNA into Aim2 -/macrophages, in which the dominant AIM2-dependent inflammasome response to exogenous DNA in cytosol has been removed, nevertheless enhanced caspase-1-dependent cytokine secretion in response to LPS and ATP. Cytosolic mtDNA was insufficient to stimulate the secretion of IL-1β and IL-18 on its own but required at a minimum the presence of LPS 6, 7 . That finding may explain why Map1lc3b -/and Becn1 +/macrophages did not constitutively secrete more IL-1β and IL-18 in the basal state, despite the finding that they had slightly more mtDNA in the cytoplasm at baseline. Although the AIM2 inflammasome clearly has a dominant role in response to transfected DNA and particular intracellular pathogens 23, 24 , it is worth noting that other cytosolic DNA sensors potentially could serve as the dominant receptors for cytosolic mtDNA in our model 37, 38 . Further research will be needed to clarify the downstream mechanism by which cytosolic mtDNA contributes to caspase-1 activation during stimulation with LPS and ATP.
In this study, we have shown the physiological relevance of autophagic proteins in regulating caspase-1-mediated inflammatory responses in two animal models of sepsis: the endotoxic shock model and the CLP model of polymicrobial sepsis. In addition, our clinical data confirmed that circulating plasma IL-18 concentrations were higher in patients with sepsis. Considerable autophagic vacuolization has been observed in liver biopsies obtained from patients who died of sepsis 39 . However, it is unclear whether that observation represented more autophagic activity in septic patients or downstream inhibition of autophagy that led to the inappropriate accumulation of autophagosomes. As sepsis has long been recognized as a condition that produces mitochondrial dysfunction in humans 40, 41 , further research is needed to investigate whether autophagy is dysregulated by septic conditions and thus contributes to sepsis-induced mitochondrial dysfunction.
In conclusion, our study has provided a mechanistic explanation for how autophagy, a core cellular housekeeping process, modulates caspase-1-mediated immune responses. Agents that stimulate autophagic activity may confer beneficial anti-inflammatory effects through the improvement of mitochondrial quality control and the removal of molecules such as mitochondrial ROS and cytosolic mtDNA. It might be useful to investigate the potential for therapeutic targeting of autophagic processes to mitigate inflammatory diseases.
METHODS
Methods and any associated references are available in the online version was isolated from 200 µl of the cytosolic fraction as described above. The copy number of DNA encoding cytochrome c oxidase 1 was measured by quantitative real-time PCR with same volume of the DNA solution.
Generation of mtDNA-deficient ρ 0 cells. J774A.1 macrophages were grown in DMEM supplemented with 10% (vol/vol) FCS, pyruvate (100 µg/ml) and uridine (50 µg/ml) as described 14, 18 . EtBr (100 ng/ml) was added to the medium for 2 weeks. Depletion of mtDNA was evaluated by quantitative real-time PCR as described above. For activation of caspase-1, cells were incubated for 4 h with LPS (100 ng/ml) after the medium was exchanged with fresh complete medium containing pyruvate and uridine, and then cells were stimulated with ATP (5 mM) 47 .
Protein transfection. BMDMs prepared at a confluency of 70-80% in 24 wells were washed twice with warm DMEM without FBS, then were transfected for 4 h at 37 °C with 3 µg DNase I or lactate dehydrogenase through the use of PULSin reagent (Polyplus transfection). After removal of the media, cells were incubated for 2 h in complete growth media, and then primed for 4 h with LPS, followed by stimulation with ATP.
Isolation and transfection of mtDNA. Mouse mtDNA was isolated from thioglycollate-elicited mouse peritoneal macrophages with an mtDNA isolation kit (Biovison). Peritoneal macrophages were incubated for 4 h with LPS (200 ng/ ml) and then were transfected for 6 h with the isolated mtDNA through the use of Lipofectamine 2000 (Invitrogen) as described 23 .
RNA-mediated interference. Small interfering RNA duplexes were from Dharmacon. Macrophages were plated on 24-well plates at a density of 3 × 10 5 cells per well and were transfected with small interfering RNA (75 ng per well) through the use of HiPerFect Transfection reagent (Qiagen).
In vivo experiments. Male mice (8-10 weeks old) were injected intraperitoneally with Escherichia coli LPS at a dose of 12 mg per kg body weight. CLP was done as described 48 . The mouse cecum was exposed through a 1.5-cm incision. The cecum was ligated below the ileocecal valve with a 6-0 silk suture without bowel obstruction and was then punctured with a 19-gauge needle (one hole injury). Sham operation consisted of the same procedure without ligation and perforation of the cecum. After surgery, mice were injected with 1 ml physiological saline solution subcutaneously.
Human study. The Research Registry and Human Sample Repository for the Study of the Biology of Critical Illness collects demographic, clinical information and blood specimens from patients with critical illness in the medical intensive care unit of the Brigham and Women's Hospital. That study is approved by Partners Human Research Committee (protocol 2008-P-000495).
Statistical analysis. Student's t-test was used for statistical analysis. Survival was analyzed with the log-rank test. P values of less than < 0.05 were considered statistically significant.
